ArticleBMJ open2023

Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable: intermediate-risk prostate cancer-a protocol for a randomised controlled trial.

Justinas Jonušas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.